Hyperglucagonemia during insulin deficiency accelerates protein catabolism
- PMID: 3303968
- DOI: 10.1152/ajpendo.1987.253.2.E208
Hyperglucagonemia during insulin deficiency accelerates protein catabolism
Abstract
Hyperglucagonemia coexists with insulin deficiency or insulin resistance in many conditions where urinary nitrogen excretion is increased, but the precise role of glucagon in these conditions is controversial. The purpose of this study was to evaluate the effect of hyperglucagonemia on protein metabolism in insulin-deficient subjects. We used the stable isotope of an essential amino acid (L-[1-13C]leucine) as a tracer of in vivo protein metabolism. A combined deficiency of insulin and glucagon was induced by intravenous infusion of somatostatin. Hyperglucagonemia and hypoinsulinemia were induced by infusions of somatostatin and glucagon. When somatostatin alone was infused leucine flux increased, indicating a 6-17% increase in proteolysis. When somatostatin and glucagon were infused, leucine flux increased, indicating a 12-32% increase in proteolysis. The increase in leucine flux during the infusion of somatostatin and glucagon was higher than the increase during infusion of somatostatin alone. Somatostatin alone did not change leucine oxidation, whereas the somatostatin plus glucagon increased leucine oxidation 100%. We conclude that hyperglucagonemia accelerates proteolysis and leucine oxidation in insulin-deficient humans.
Similar articles
-
Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate.Diabetes. 1998 Nov;47(11):1748-56. doi: 10.2337/diabetes.47.11.1748. Diabetes. 1998. PMID: 9792544
-
Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.J Clin Endocrinol Metab. 1987 May;64(5):896-901. doi: 10.1210/jcem-64-5-896. J Clin Endocrinol Metab. 1987. PMID: 2881943
-
Bradykinin attenuates glucagon-induced leucine oxidation in humans.Am J Physiol. 1990 Aug;259(2 Pt 1):E239-45. doi: 10.1152/ajpendo.1990.259.2.E239. Am J Physiol. 1990. PMID: 1974388
-
Glucagon and diabetes.Med Clin North Am. 1978 Jul;62(4):713-22. doi: 10.1016/s0025-7125(16)31767-9. Med Clin North Am. 1978. PMID: 355737 Review.
-
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.J Clin Invest. 2012 Jan;122(1):4-12. doi: 10.1172/JCI60016. Epub 2012 Jan 3. J Clin Invest. 2012. PMID: 22214853 Free PMC article. Review.
Cited by
-
Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes.Cell Rep. 2016 May 17;15(7):1394-1400. doi: 10.1016/j.celrep.2016.04.024. Epub 2016 May 5. Cell Rep. 2016. PMID: 27160898 Free PMC article. Clinical Trial.
-
Early hormonal changes affect the catabolic response to trauma.Ann Surg. 1993 Oct;218(4):476-89; discussion 489-91. doi: 10.1097/00000658-199310000-00008. Ann Surg. 1993. PMID: 8215639 Free PMC article.
-
Triple Agonism Based Therapies for Obesity.Curr Cardiovasc Risk Rep. 2025;19(1):18. doi: 10.1007/s12170-025-00770-z. Epub 2025 Jul 28. Curr Cardiovasc Risk Rep. 2025. PMID: 40741227 Free PMC article. Review.
-
Nutrient interactions with reference to amino acid and protein metabolism in non-ruminants; particular emphasis on protein-energy relations in man.Z Ernahrungswiss. 1991 Dec;30(4):239-67. doi: 10.1007/BF01651955. Z Ernahrungswiss. 1991. PMID: 1788993 Review.
-
Insulin Regulation of Proteostasis and Clinical Implications.Cell Metab. 2017 Aug 1;26(2):310-323. doi: 10.1016/j.cmet.2017.06.010. Epub 2017 Jul 14. Cell Metab. 2017. PMID: 28712655 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical